Sissetulev kiriAvalik
Request for information
Ravimiamet · 4. veebruar 2026
- Viit
- L-1/692-1
- Registreeritud
- 4. veebruar 2026
- Dokumendi liik
- Sissetulev kiri
- Adressaat
- European Directorate for the Quality of Medicines & HealthCare
- Saabumis/saatmisviis
- e-post
- Funktsioon
- L Ravimite kvaliteedi kontrollimine
- Sari
- L-1 Labori kirjavahetus
- Toimik
- L-1/2026
- Vastutaja
- Eveli Holst (RA, Peadirektori asetäitja valdkond, Labor)
Sisu (failidest)
Saatja: BAUTZ Ketty <[email protected]>
Saatmisaeg: esmaspäev, 2. veebruar 2026 16:21
Adressaat: Ravimiamet <[email protected]>; Signe Leito <[email protected]>
Teema: Request of information - Aripiprazole Generics Programme-
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral
palume linke ja faile mitte avada.
Dear Colleagues,
I hope you are doing well!
from EMA regarding the label check
questionnaires that have been filled in by the samplers for Aripiprazole.
would still have samples left to get scans of the outer packages.
If yes, we would like to receive pictures of the following samples:
Aripiprazole Zentiva IT _ Sample J
Aripiprazole Sandoz SE _ sample G
Aripiprazole Sandoz EL _ sample I
Aripiprazole Mylan pharma HR _ Sample E
These can be uploaded here: https://act.edqm.eu/s/SRkjRyfw5pxWDwf
Many thanks in advance!
Ketty